Medical economics

Pfizer to buy Array BioPharma in deal worth $11.4 billion

Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring.

Health

FDA chief Scott Gottlieb steps down after nearly 2 years

Food and Drug Administration Commissioner Scott Gottlieb is stepping down after nearly two years leading the agency's response to a host of public health challenges, including the opioid epidemic, rising drug prices and underage ...

page 11 from 22